I'm very happy to participate in the parallel session of the 2023 Hongqiao International Economic Forum, and to be here in person to share the discussions on the global drug safety governance and Chinese drug regulatory practice. This important topic requires opening-up, information sharing and enhancing cooperation among countries to jointly ensure patients can access to the treatments they need.

The forum serves as a crucial platform for global exchanges. It promotes international cooperation and brings new opportunities for multinational companies like Sanofi to continue development in China.

I'm looking forward to getting valuable insights and exploring potential areas of cooperation with everyone here at the forum. Thank you！